When you buy through our links, we may earn a commission. Products or services may be offered by an affiliated entity. Learn more.
Cheapest Compounded Semaglutide Online in 2026: Where to Buy It Safely
Updated on September 9, 2026
I tested 40+ compounded semaglutide providers and tracked what each actually charges past the headline price. Here are the 6 that deliver real value without cutting safety corners, including how the post-shortage FDA framework affects who you can legally buy from now.
Top Picks Comparison Table
These 6 providers survived a 12-month true-cost calculation, pharmacy licensing checks, and a hands-on intake walkthrough. True Monthly Cost is what you actually pay after teaser months, not the headline. A separate 2026 comparison sets out which providers publish a real maintenance price.
Provider
Starting price
Score
Apply now
Editor’s note
Prices are accurate at the time of publication. We update frequently, but pricing can change quickly.
YOU MIGHT BE WONDERING
Why trust these top picks?
I tested 40+ GLP-1 telehealth providers, tracked what each charges over a 12-month cycle (not just the discounted first month), and verified pharmacy licensing. The 6 below are the cheapest that still meet our doctor-approved safety baseline.
What Changed in 2025 for Compounded Semaglutide?
The legal ground under compounded semaglutide moved twice in 2025, and most articles on this topic still describe the old rules.
In February 2025, the FDA issued a declaratory order resolving the semaglutide injection shortage [1]. That decision started two enforcement clocks. 503A pharmacies lost their shortage-based enforcement discretion in April 2025; 503B outsourcing facilities lost theirs on May 22, 2025. The carveout that let pharmacies mass-compound semaglutide in bulk is gone.
In April 2026, the FDA proposed removing semaglutide from the 503B bulks list entirely [2]. Comments are open through June 29, 2026.
What this means for you: compounded semaglutide is still legal under Section 503A when prescribed for an individual patient’s documented medical need. A real prescriber, a state-licensed compounding pharmacy, a patient-specific prescription. That path is intact. The bulk-compounding shortcut that funded a lot of $39/month marketing in 2024 is gone. The FDA has also flagged adverse events from compounded GLP-1 dosing errors and fraudulent products mislabeled as legitimate compounds [3]. Pick a 503A-compliant operator that names its pharmacy and prescriber, and the regulatory risk drops dramatically.
How I chose top providers?
Here’s the buyer flow I ran for every provider. Shed’s intake is the canonical example because it’s the most fully documented in our audit notes.
Learn more about how providers are scored in our review methodology
How We Rate: Each provider was scored on five axes (True Cost, Patient Support, Medication Handling, Transparent Operations, Patient Reviews) with sub-criteria rated Excellent (80-100), Good (50-79), or Bad (0-49).
Provider Rankings
Pomegranate (Best Overall Value)
GobyMeds (Best Highest Audited Score)
Shed (Best for Wegovy Crossover)
Amble (Best for Bundle Pricing)
Mochi (Best for Headline Discounts)
Eden (Best for Comprehensive Care)
Pomegranate ranks highest and prices lowest. Shed is the strongest fallback for branded backup via NovoCare.
Compare GLP-1 Weight Loss Options
Branded GLP-1s
Semaglutide for Weight Loss
Tirzepatide for Weight Loss
GLP-1 Costs Explained
Ready to finally stop fighting?
Join thousands of women who got their mental freedom back with the right GLP-1 program.
Find your perfect match
FAQ
Is compounded tirzepatide cheaper than compounded semaglutide?
How do I get semaglutide for $25 a month?
Compounded semaglutide is usually the more affordable option, averaging about $299 per month. Compounded tirzepatide tends to cost more, often $299–$399 or higher. The price gap isn’t random; it reflects clinical research showing tirzepatide generally produces greater weight loss and stronger improvements in blood sugar control than semaglutide, making it the more potent (and pricier) choice.
How do I get semaglutide for $25 a month?
Compounded semaglutide is not available for only $25 a month but patients can access brand name options for $25 a month with insurance coverage paired with a manufacturer savings card. The PAN Foundation also offers an insurance copay assistance program to help people with type 2 diabetes afford Ozempic and to reduce out-of-pocket costs for those who use Wegovy or Zepbound for weight management. Both options depend on eligibility but can significantly lower out-of-pocket costs compared to typical pharmacy prices.
How much will Costco charge for Ozempic?
Costco charges $499 for Ozempic, partnering with Novo Nordisk to provide customers access to manufacturer prices. That means eligible patients can expect to pay $499 for a 28-day supply, $998 for 56 days, or $1,497 for 84 days with a valid prescription and no government insurance. Prices may vary slightly by location, but Costco uses the same fixed cash-pay pricing available at participating US pharmacies.
How much does compounded semaglutide cost a month?
Compounded semaglutide usually runs around $299 per month, making it noticeably more affordable than the $499 cash-pay option offered directly through Novo Nordisk. The lower price point is a major reason so many people choose compounded versions, especially when insurance won’t cover brand-name medications or the out-of-pocket costs are still too high. For a more detailed breakdown of pricing across brands and clinics, visit our complete guide to semaglutide pricing.
Is RO or HERS cheaper?
Hers is typically cheaper than Ro because it sells compounded semaglutide, which usually costs around $250–$299 per month. Ro offers only brand-name medications like Ozempic or Wegovy and therefore uses the manufacturer’s cash-pay pricing (around $499 per month) plus a membership fee. In short, Ro is more expensive but provides FDA-approved brands, while Hers is lower cost due to compounded versions.
Sources
- U.S. Food & Drug Administration. Declaratory Order: Resolution of Shortages of Semaglutide Injection Products and Supply Status. FDA Center for Drug Evaluation and Research, 2025. https://www.fda.gov/media/185526/download?attachment=
- U.S. Food & Drug Administration. FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List. FDA Press Announcements, 2026. https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list
- U.S. Food & Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA Postmarket Drug Safety Information for Patients and Providers, 2024. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- Ard, J.D., Lewis, K.H., Moore, J.B. Lifestyle Interventions for Obesity in the Era of GLP-1 Receptor Agonists. JAMA. 2024;332(1):16-18. PMID: 38744427. https://pubmed.ncbi.nlm.nih.gov/38744427/
- Burgess, E., Hassmén, P., Pumpa, K.L. Determinants of adherence to lifestyle intervention in adults with obesity: a systematic review. Clinical Obesity. 2017;7(3):123-135. PMID: 28296261. https://pubmed.ncbi.nlm.nih.gov/28296261/
- Moiz, A., Filion, K.B., Tsoukas, M.A., Yu, O.H., Peters, T.M., Eisenberg, M.J. Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation. American Journal of Medicine. 2025;138(6):934-940. PMID: 39892489. https://pubmed.ncbi.nlm.nih.gov/39892489/
- Wilding, J.P.H., Batterham, R.L., Calanna, S., et al.; STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002. PMID: 33567185. doi:10.1056/NEJMoa2032183. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
Disclaimer:
This article is for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before starting any new treatment.




















